One year ago, President Trump signed an executive order directing his administration to develop policy recommendations to protect access to in vitro fertilization (IVF), expand its availability, and lower its cost to patients. Then in October, the administration announced additional measures to lower costs for IVF and common fertility drugs and explore pathways like expanded employer benefits or excepted benefit categories for assisted reproductive technologies. While this included joint efforts across federal agencies to make this costly intervention more affordable, the administration stopped short of imposing broad new federal mandates for insurance coverage or direct government funding of IVF.


